Hansoh Pharmaceutical Group Company Limited
3692Pharmaceuticals
HK$33.08+2.92%As of Oct 29vs prior close
- Market cap
- $25.6B
- P/E (TTM)
- 25.5×
- P/E (FY1)
- 25.9×
- From 52W high
- −22.60%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥15.9B
- Net margin
- 42.01%
- Dividend yield
- 1.47%
Nomior Score
50
Steady ProfileBottom 49% of the scored universe
Growth55
Quality66
Value28
Momentum45
Resilience59
Growth
+17.00%revenue a year over 3 fiscal years
YE22 CN¥9.4BLTM CN¥15.9B
Connections
Revenue to profitYE25
37% of revenue became net profit, up 1 pt on a year.